Using scans to find radiation-sensitive esophageal cancer
Part of Cancer, Digestive system clinical trials.
This study tests whether a special imaging scan (functional imaging) can identify which esophageal cancers respond best to radiation. If you have stage II–IVA esophageal cancer and meet the health criteria, joining may help personalize your treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have squamous cell, undifferentiated, or adenocarcinoma of the esophagus (stages II–IVA, but not T4b).
- You are able to care for yourself and are up and about at least half the day (ECOG 0–2).
- You have had full staging tests (endoscopy, ultrasound, CT scans, and lung function test) and results show adequate organ function (like blood counts, liver, kidney, and lung health).
- You have not had prior high-dose radiation to your chest or abdomen.
- You do not have cancer that has spread to distant organs (M1 stage).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks whether MRI and CT scans can better measure how esophageal or stomach-junction tumors respond during chemoradiotherapy and help doctors map the exact treatment area. It may help improve targeting while you receive standard treatment.
This trial studies whether proton therapy can better treat early-to-mid stage esophagus cancer while aiming to reduce side effects to nearby organs. Proton therapy uses a targeted type of radiation, and participants are also checked to be eligible for curative surgery.
This Phase 1 study uses specialized imaging (including MRI) to better “see” low-oxygen areas in esophageal cancer and help guide individualized radiation treatment. It aims to improve how radiation is planned and delivered while checking safety.
This trial uses a special PET/CT scan to see how well your esophageal cancer responds to chemotherapy and radiation. It helps doctors find out if the treatment is working early on.
This trial tests whether a special PET scan called FAPI-PET can better show the edges of esophageal tumors before surgery. It may help doctors plan more precise surgery.
This study tests whether special PET/CT scans can help predict how well immunotherapy works before surgery for esophageal cancer. It aims to improve treatment planning by identifying patients who may need additional therapy.
Hear when a new Esophagus Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.